Abstract
A decreased ratio of branched-chain amino acids (BCAA) to aromatic amino acids (AAA) is considered an important pathogenetic factor in hepatic encephalopathy (HE). A relationship between the deranged BCAA/AAA ratio and dopaminergic dysfunction through the formation of “false” neurotransmitters has been postulated. The intermediate lobe of the pituitary is more pronounced in dogs than in humans and because it is primarily under dopaminergic inhibitory influence, it may serve as an indicator of alterations in dopaminergic neurotransmission. We investigated the effects of a diet with a high BCAA/AAA ratio (HR) and an isonitrogenous diet with a low BCAA/AAA ratio (LR) on several physical and biochemical parameters including pituitary function in dogs with portocaval shunts and 40% hepatectomy and in sham-operated pair-fed controls, in a double-blind, randomized cross-over study. Portocaval-shunted dogs had hyperammonemia (33±3 μM (mean ± SEM) before and 214±21 after surgery)) and signs of HE. Their BCAA/AAA ratio in plasma and CSF decreased from 4.3±0.3 and 2.3±0.3 before surgery to 1.3±0.1 and 0.5±0.1 after surgery, respectively. These parameters remained unaltered in the control dogs. The consumption of the LR diet was significantly higher than consumption of the HR diet. In the portocaval-shunted dogs, plasma ammonia concentration was higher on the HR diet than on the LR diet (344±52 v 246±45) and the HE grade was worse. The BCAA /AAA ratio remained abnormal in HE dogs during the feeding of both diets. The basal and haloperidol-stimulated release of α-melanotropin and cortisol in plasma were not significantly different between or within groups during any period. In contrast, urinary cortisol excretion was increased in the HE dogs after surgery (urinary cortisol:creatinine ratio (×10−6) 8.5±1.4 before and 30.4±8.9 after surgery). The basal plasma concentration of adrenocorticotropin in HE dogs was decreased after surgery (68.3±10.2 ng/L before and 40.8±4.4 after surgery). This indicates a non-pituitary-dependent hyperresponsiveness of the adrenals. We conclude from these results that chronic HE in dogs is not associated with an abnormal dopaminergic neurotransmission at least at the level of the pituitary, and that it is not the content of the dietary neutral amino acids but rather the total protein intake that may have a beneficial effect on HE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bianchi G.P., Marchesini G., Zoli M., Abbiati R., Ferrario E., Fabbri A., and Pisi E. (1992). Oral BCAA supplementation in cirrhosis with chronic encephalopathy: Effects on prolactin and estradiol levels. Hepatogastroenterology 39:443–446.
Butterworth R.F., Spahr L., Fontaine S., and Pomier Layrargues G. (1995). Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab. Brain Dis. 10:259–267.
Chalasani N., and Gitlin N. (1996). Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Am. J. Gastroenterol. 91:1266–1268.
Chamuleau R.A.F.M. (1996). Animal models of hepatic encephalopathy. Semin. Liver Dis. 16:265–270.
Charlton M.R. (1996). Branched-chains revisited. Gastroenterology 111:252–255.
Christie M.L., Sack D.M., Pomposelli J., and Horst D. (1985). Enriched branched-chain amino acid amino acid formula versus a casein-based supplement in the treatment of cirrhosis. J. Parenter. Enteral Nutr. 6:671–678.
Conn H.O. (1988). The hepatic encephalopathies. In (M.D. Conn, and J. Bircher, eds.) Hepatic Encephalopathy: Management with Lactulose and Related Carbohydrates, 1st ed, Medi-Ed Press, East Lansing, Michigan, pp. 3–14.
Eriksson L.S., and Conn H.O. (1989). Branched-chain amino acids in the management of hepatic encephalopathy — An analysis of variants. Hepatology 10:228–246.
Eriksson L.S., Persson A., and Wahren J. (1982). Branched-chain amino acids in the treatment of chronic encephalopathy. Gut 23:801–806.
Fischer J.E., and Baldessarini R.J. (1971). False neurotransmitters and hepatic failure. Lancet ii:75–79.
Fischer J.E., Rosen H.M., Ebed A.M., James J.H., Keane J.M., and Soeters P.B. (1976). The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91.
Freund H., Yoshimura N., and Fischer J.E. (1979). Chronic hepatic encephalopathy: Long-term therapy with a branched-chain amino-acid-enriched elemental diet. J. Am. Med. Assoc. 242:347–349.
Holecek M., Mraz J., and Tilser I. (1996). Plasma amino acids in four models of experimental injury in rats. Amino Acids 10:229–241.
Horst D., Grace N.D., Conn H.O., Schiff E., Schenker S., Viteri A., Law D., and Atterbury C.E. (1984). Comparison of dietary protein with an oral branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: A double-blind controlled trial. Hepatology 4:279–287.
Iber F.L., Rosen H., Levenson S.M, and Chalmers T.C. (1957). The plasma amino acids in patients with liver failure. J. Lab. Clin. Sci. 50:417–425.
Kemppainen R.J., and Sartin J.L. (1987). Differential regulation of peptide release by the canine pars distalis and pars intermedia. In (A. Rijnberk, and T.B. van Wimersma Greidanus, eds.) Frontiers in Hormone Research: Comparative Pathophysiology of Regulatory Peptides, Karger, Basel, pp. 18–27.
Kooistra H.S., Greven S.H., Mol J.A., and Rijnberk A. (1997). Pulsatile secretion of α-MSH and the differential effects of dexamethasone and haloperidol on the secretion of α-MSH and ACTH in dogs. J. Endocrinol. 152:113–121.
LaFlamme D.P., Allen S.W., and Huber T.L. (1993). Apparent dietary protein requirement for dogs with portosystemic shunt. Am. J. Vet. Res. 54:719–723.
Marchesini G., Dioguardi F.S., Bianchi G.P., Zoli M., Bellati G., Roffi L., and Martines D. (1990). Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind, casein-controlled study. J. Hepatol. 11:92–101.
McGhee A., Henderson J.M., Millikan W.J.J., Bleier J.C., Vogel R., Kassouny M., and Rudman D. (1983). Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann. Surg. 197:288–293.
Meyer H.P., and Rothuizen J. (1993). Determination of the percentage of free cortisol in plasma in the dog by ultrafiltration/dialysis. Domest. Anim. Endocrinol. 10:45–53.
Meyer H.P., Legemate D.A., How K.L., van den Brom W.E., Voorhout G., Chamuleau R.A.F.M., van den Ingh T.S.G.A.M., and Rothuizen J. (1999). End-to-side portocaval anastomosis and partial hepatectomy in the dog as a model for chronic hepatic encephalopathy. J. Hepatol.(submitted).
Morgan M.Y. (1990). Branched chain amino acids in the management of chronic liver disease — Facts and fantasies. J. Hepatol. 11:133–141.
Mousseau D.D., Perney P., Pomier Layrargues G., and Butterworth R.F. (1993). Selective loss of pallidal dopamine D2receptor density in hepatic encephalopathy. Neurosci. Lett. 162:192–196.
Mullen K.D., and McCullough A.J. (1989). Problems with animal models of chronic liver disease: Suggestions for improvement in standardization. Hepatology 9:500–505.
Nompleggi D.J., and Bonkovsky H.L. (1994). Nutritional supplementation in chronic liver disease: An analytical review. Hepatology 19:518–533.
Olde Damink S.W.M., Dejong, C.H.C., Deutz N.E.P., and Soeters P.B. (1997). Decreased plasma and tissue isoleucine levels after simulated gastrointestinal bleeding by blood gavages in chronic portacaval shunted rats. Gut 40:418–424.
Parola A.L., Yamamura H.I., and Laird II H.E. (1993). Minireview: Peripheral-type benzodiazepine receptors. Life Sci. 52:1329–1342.
Plauth M., Egberts E.H., Hamster W., Torok M., Muller P.H., Brand O., Furst P., and Dolle W. (1993). Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J. Hepatol. 17:308–314.
Popken R.J., Kropveld D., Oosting J., and Chamuleau R.A. (1983). Quantitative analysis of EEG power spectra in experimental hepatic encephalopathy. Neuropsychobiology 9:235–243.
Rijnberk A., van Wees A., and Mol J.A. (1988a). Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet. Rec. 122:178–180.
Rijnberk A., Mol J.A., Kwant M.M., and Croughs R.J.M. (1988b). Effects of bromocriptine on corticotrophin, melanotrophin and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism. J. Endocrinol. 118:271–277.
Rothuizen J. and Mol J.A. (1987). The pituitary-adrenocortical system in canine hepatoencephalopathy. In (A. Rijnberk, and T. B. van Wimersma Greidanus, eds.) Frontiers of Hormone Research: Comparative Pathophysiology of Regulatory Peptides. Karger, Basel, pp. 28–36.
Smith A.T., Rossi-Fanelli F., Ziparo V., James J.H., Perelle B.A., and Fischer J.E. (1978). Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann. Surg. 187:343–350.
Soeters P.B. and Fischer J.E. (1976). Insulin, glucagon, aminoacid imbalance and hepatic encephalopathy. Lancet ii:880–882.
Tessari P., Biolo G., Inchiostro S., Orlando R., Vettore M., and Sergi G. (1993). Leucine and phenylalanine kinetics in compensated liver cirrhosis — Effects of insulin. Gastroenterology 104:1712–1721.
van Berlo C.L.H., van de Bogaard A.E., van der Heijden M.A.H., van Eijck H.M.H., Janssen M.A., Bost M.C., and Soeters P.B. (1989). Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs. Hepatology 10:315–323.
van der Rijt C.C.D., and Schalm S.W. (1991). Spectral analysis in hepatic encephalopathy. In (F. Bengtsson, B. Jeppson, T. Almda, and H. Vilstrup, eds.) Hepatic Encephalopathy and Metabolic Nitrogen Exchange, CRC Press, Boca Raton, pp. 59–66.
van Eijck H.M.H., van der Heijden M.A.H., van Berlo C.L.H., and Soeters P.B. (1988). Fully automated liquid-chromatographic determination of amino acids. Clin. Chem. 34:2510–2513.
Yamato M., Muto Y., Yoshida T., Kato M., and Moriwaki H. (1995). Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. Int. Hepatol. Comm. 3:91–96.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meyer, H.P., Chamuleau, R.A., Legemate, D.A. et al. Effects of a Branched-Chain Amino Acid-Enriched Diet on Chronic Hepatic Encephalopathy in Dogs. Metab Brain Dis 14, 103–115 (1999). https://doi.org/10.1023/A:1020757730386
Issue Date:
DOI: https://doi.org/10.1023/A:1020757730386